Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication
详细信息 查看全文
- 作者：Giuseppe Giugliano (1)
Cinzia Perrino (1)
Vittorio Schiano (1)
Linda Brevetti (1)
Anna Sannino (1)
Gabriele Giacomo Schiattarella (1)
Giuseppe Gargiulo (1)
Federica Serino (1)
Marco Ferrone (1)
Fernando Scudiero (1)
Andreina Carbone (1)
Antonio Bruno (1)
Bruno Amato (2)
Bruno Trimarco (1)
Giovanni Esposito (1) - 刊名：BMC Surgery
- 出版年：2012
- 出版时间：November 2012
- 年：2012
- 卷：12
- 期：1-supp
- 全文大小：157KB
- 参考文献：1. Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, / et al.: Vorapaxar in the secondary prevention of atherothrombotic events. / N Engl J Med 2012, 366:1404-413. CrossRef
2. Cassese S, Esposito G, Mauro C, Varbella F, Carraturo A, Montinaro A, Cirillo P, Galasso G, Rapacciuolo A, Piscione F: MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: study design and rationale. / Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012, 79:1118-126. CrossRef
3. Amato B, Iuliano GP, Markabauoi AK, Piscitelli V, Masone S, Compagna R, Esposito G, Piscione F: Endovascular procedures in critical leg ischemia of elderly patients. / Acta bio-medica : Atenei Parmensis 2005,76(Suppl 1):11-5.
4. Perrino C, Scudiero L, Petretta MP, Schiattarella GG, De Laurentis M, Ilardi F, Magliulo F, Carotenuto G, Esposito G: Total occlusion of the abdominal aorta in a patient with renal failure and refractory hypertension: a case report. / Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace /Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo 2011, 76:43-6.
5. Esposito G, Cassese S, Gargiulo G, Sannino A, Schiattarella GG, Piscione F, Chiariello M: Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report. / J Cardiovasc Med (Hagerstown) 2011, 12:366-69. CrossRef
6. Vamos EP, Harris M, Millett C, Pape UJ, Khunti K, Curcin V, Molokhia M, Majeed A: Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study. / BMJ 2012, 345:e5567. CrossRef
7. Marciano C, Galderisi M, Gargiulo P, Acampa W, D'Amore C, Esposito R, Capasso E, Savarese G, Casaretti L, Lo Iudice F, / et al.: Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease. / European journal of nuclear medicine and molecular imaging 2012, 39:1199-206. CrossRef
8. Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, Esposito G, Carriero MV, Rapacciuolo A, Di Lorenzo E, Stabile E, / et al.: Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. / Circulation 2001, 103:2980-986. CrossRef
9. Giugliano G, Di Serafino L, Perrino C, Schiano V, Laurenzano E, Cassese S, De Laurentis M, Schiattarella GG, Brevetti L, Sannino A, / et al.: Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. / International journal of cardiology 2012.
10. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, Strandness DE Jr., Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. / Circulation 1996, 94:3026-049. CrossRef
11. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE: Peripheral arterial disease in the elderly: The Rotterdam Study. / Arterioscler Thromb Vasc Biol 1998, 18:185-92. CrossRef
12. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, / et al.: Peripheral arterial disease detection, awareness, and treatment in primary care. / JAMA 2001, 286:1317-324. CrossRef
13. Brevetti G, Giugliano G, Brevetti L, Hiatt WR: Inflammation in peripheral artery disease. / Circulation 122:1862-875.
14. Schiano V, Sirico G, Giugliano G, Laurenzano E, Brevetti L, Perrino C, Brevetti G, Esposito G: Femoral plaque echogenicity and cardiovascular risk in claudicants. / JACC Cardiovascular imaging 2012, 5:348-57. CrossRef
15. Bosevski M: Peripheral arterial disease and diabetes. / Prilozi /Makedonska akademija na naukite i umetnostite, Oddelenie za bioloski i medicinski nauki = Contributions /Macedonian Academy of Sciences and Arts, Section of Biological and Medical Sciences 2012, 33:65-8.
16. Indolfi C, Stabile E, Perrino C, Chiariello M: Mechanisms of restenosis after angioplasty and approach to therapy (Review). / International journal of molecular medicine 1998, 2:143-48.
17. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, / et al.: ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). / European heart journal 2011, 32:2851-906. CrossRef
18. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). / J Vasc Surg 2007,45(Suppl S):S5-7. CrossRef
19. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D: Mortality over a period of 10 years in patients with peripheral arterial disease. / N Engl J Med 1992, 326:381-86. CrossRef
20. Rockson SG, Cooke JP: Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. / Adv Intern Med 1998, 43:253-77.
21. Cook TA, O'Regan M, Galland RB: Quality of life following percutaneous transluminal angioplasty for claudication. / Eur J Vasc Endovasc Surg 1996, 11:191-94. CrossRef
22. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, / et al.: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. / Circulation 2006, 113:e463-54. CrossRef
23. Keeling AN, Naughton PA, O'Connell A, Lee MJ: Does percutaneous transluminal angioplasty improve quality of life? / J Vasc Interv Radiol 2008, 19:169-76. CrossRef
24. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D: Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. / Arterioscler Thromb Vasc Biol 1999, 19:538-45. CrossRef
25. McKenna M, Wolfson S, Kuller L: The ratio of ankle and arm arterial pressure as an independent predictor of mortality. / Atherosclerosis 1991, 87:119-28. CrossRef
26. Allaqaband S, Kirvaitis R, Jan F, Bajwa T: Endovascular treatment of peripheral vascular disease. / Curr Probl Cardiol 2009, 34:359-76. CrossRef
27. Breek JC, Hamming JF, De Vries J, Aquarius AE, van Berge Henegouwen DP: Quality of life in patients with intermittent claudication using the World Health Organisation (WHO) questionnaire. / Eur J Vasc Endovasc Surg 2001, 21:118-22. CrossRef
28. iBarletta G, Perna S, Sabba C, Catalano A, O'Boyle C, Brevetti G: Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. / Vasc Med 1996, 1:3-.
29. Leon AS, Connett J, Jacobs DR Jr., Rauramaa R: Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial. / JAMA 1987, 258:2388-395. CrossRef
30. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, / et al.: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. / JAMA 1995, 273:402-07. CrossRef
31. Paffenbarger RS Jr., Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB: The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. / N Engl J Med 1993, 328:538-45. CrossRef
32. Husmann M, Dorffler-Melly J, Kalka C, Diehm N, Baumgartner I, Silvestro A: Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease. / J Vasc Surg 2008, 48:1211-216. CrossRef
33. Brevetti G, Schiano V, Chiariello M: Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? / Atherosclerosis 2008, 197:1-1. CrossRef
34. Khaira HS, Nash GB, Bahra PS, Sanghera K, Gosling P, Crow AJ, Shearman CP: Thromboxane and neutrophil changes following intermittent claudication suggest ischaemia-reperfusion injury. / Eur J Vasc Endovasc Surg 1995, 10:31-5. CrossRef - 作者单位：Giuseppe Giugliano (1)
Cinzia Perrino (1)
Vittorio Schiano (1)
Linda Brevetti (1)
Anna Sannino (1)
Gabriele Giacomo Schiattarella (1)
Giuseppe Gargiulo (1)
Federica Serino (1)
Marco Ferrone (1)
Fernando Scudiero (1)
Andreina Carbone (1)
Antonio Bruno (1)
Bruno Amato (2)
Bruno Trimarco (1)
Giovanni Esposito (1)
1. Department of Clinical Medicine and Cardiovascular and Immunological Sciences, “Federico II-University- via Pansini 5, 80131, Naples, Italy
2. Department of General, Geriatric, Oncologic Surgery and Advanced Technologies, “Federico II-University- via Pansini 5, 80131, Naples, Italy
文摘
Background Lower extremity peripheral arterial disease (LE-PAD) is a highly prevalent condition among diabetic patients, associated with reduced walking capacity and a high incidence of cardiovascular events. Endovascular revascularization of lower extremities arteries improves walking performance and quality of life of diabetic patients affected by intermittent claudication, but few studies evaluated the impact of revascularization on cardiovascular outcome in this high-risk population. Accordingly, in the present study we evaluated if leg-ischemia resolution by effective lower limbs percutaneous revascularization can also impact cardiovascular outcome in a homogeneous group of diabetic patients affected by intermittent claudication. Methods 236 diabetic patients affected by LE-PAD at stage II of Fontaine’s classification, with ankle/brachial index ?.90 and one or more hemodynamically significant stenosis in at least one artery of the ileo-femoro-popliteal axis were enrolled in the study. According to the Trans-Atlantic Inter Society Consensus II recommendations, 123 (52.1%) underwent percutaneous transluminal angioplasty (PTA group), while 113 (47.9%) underwent conservative medical therapy only (MT group). The incidence of major cardiovascular events (cardiovascular death, myocardial infarction, ischemic stroke, coronary or carotid revascularization) was prospectively analyzed with Kaplan-Meier curves and the risk of developing a cardiovascular event calculated by Cox analyses. Results No baseline difference in cardiovascular risk factors were observed between the PTA and MT groups, except for a lower prevalence of males in PTA group (74.8% vs. 85.8%, p=0.034). Furthermore, patients in the PTA group showed a worse walking capacity as expressed by maximum walking distance (108.7 ± 300.9 vs 378.4 ± 552.3 meters, p<0.001). During a median follow-up of 20 months (12.0-29.0), the incidence of cardiovascular events was markedly lower in patients in the PTA group with respect to patients in the MT group (7.3% vs. 22.1%, p=0.001), and patients of the MT group had at Cox analysis a 3.9 increased risk with respect to PTA group, after adjustment for potential confounding factors (95% CI 1.1-15.3, p=0.049). Conclusions The present study shows that lower limbs revascularization of diabetic patients affected by intermittent claudication, in addition to improve walking performance, is associated with a reduction in the incidence of future major cardiovascular events.